MedPath

REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE

REBLOZYL 75 MG POLVO PARA SOLUCION INYECTABLE

Commercialized
Register Number

1201452002

Prescription Type

Uso Hospitalario

Authorization Date

Aug 17, 2020

Dosage Form

POLVO PARA SOLUCIÓN INYECTABLE

Route: VÍA SUBCUTÁNEA

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201452002
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
Yes
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

LUSPATERCEPTActive
Quantity: 75 mg
Name: LUSPATERCEPT

ATC CLASSIFICATION (3)

B03X
B03XA
B03XA06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.